Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Original Article
88 (
5
); 623-632
doi:
10.25259/IJDVL_608_2021
pmid:
35389031

Patient perception and satisfaction with a smartphone-based teledermatology service initiated during the COVID-19 pandemic at a tertiary care hospital in North India

Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India

Corresponding author: Dr. Vishal Gupta, Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India. doctor.vishalgupta@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Yadav D, Bhatia S, Ramam M, Singh V, Khanna N, Khandpur S, et al. Patient perception and satisfaction with a smartphone-based teledermatology service initiated during the COVID-19 pandemic at a tertiary care hospital in North India. Indian J Dermatol Venereol Leprol 2022;88:623-32.

Abstract

Background

Telemedicine is being increasingly used to provide healthcare to patients, particularly during the COVID-19 pandemic.

Aims

The study aimed to study patient perception and satisfaction with a smartphone-based hybrid teledermatology service initiated during the COVID-19 pandemic.

Methods

This was a cross-sectional telephonic survey including patients 18 years of age who had received a teledermatology consultation. After noting the demographic, clinical and teleconsultation details, patients were administered the Telemedicine Satisfaction Questionnaire and an additional 6-item questionnaire. Patients were also asked to give qualitative feedback and suggestions for improvement using a semi-structured interview guide.

Results

We interviewed 201 subjects. The most common diagnoses were pemphigus (27, 13.4%), superficial fungal infections (24, 11.8%), psoriasis (22, 10.9%) and dermatitis (21, 10.4%). The overall mean Telemedicine Satisfaction Questionnaire score was 4.20± 0.71. One hundred seventy-one (85.1%) patients responded that they would use teledermatology services again, while 168 (83.6%) reported satisfaction with the quality of services. A majority of the patients were largely satisfied with the various components involved, though some concerns were raised about the care perceived as not at par with physical consultations, difficulty in procuring medicines, lack of confidence in photographic diagnoses and the lack of a personal touch. Patients with urticaria (P=0.020), those who were advised a change in treatment (P=0.029) and those with improvement in their skin disease (P=0.026) were more likely to be satisfied.

Limitations

Our study was conducted during the COVID-19 pandemic when patient acceptability was likely to be higher. Only follow-up patients were included in the study.

Conclusion

Patient satisfaction levels were generally high with teledermatology. Addressing lacunae that negatively impact patient perception and satisfaction will help in greater acceptance of teledermatology services.

Keywords

Patient satisfaction
smartphone
teledermatology
telemedicine

Plain Language Summary

Telemedicine is the use of a technology-based virtual platform for remote medical consultations and it can be particularly advantageous during disasters and public health emergencies in rendering medical services at remote locations. We conducted a telephonic survey to assess patient perception and satisfaction with our smartphone-based hybrid teledermatology service initiated during the COVID-19 pandemic. Two hundred and one patients were asked to respond to the Telemedicine Satisfaction Questionnaire and an additional six-item questionnaire and were also asked to give qualitative feedback and suggestions. The overall mean Telemedicine Satisfaction Questionnaire score was 4.20± 0.71, indicating that the patients were generally satisfied with teledermatology services. Some concerns that emerged in the qualitative feedback were about the care perceived as not being at par with physical consultations, difficulty in procuring medicines, lack of confidence on photographic diagnoses and the lack of a personal touch. Patients with urticaria (hives), those who were advised a change in treatment and those with improvement in their skin disease were more likely to be satisfied with teledermatology services according to our survey.

Introduction

Telemedicine is the use of a technology-based virtual platform to remotely deliver various aspects of health information, prevention, diagnosis and medical care. Telemedicine has been used by several medical specialties, and it can be particularly advantageous during disasters and public health emergencies in rendering medical services at remote locations.1During the current COVID-19 pandemic when social distancing is emphasized and lockdowns have further reduced access to healthcare professionals, telemedicine is being increasingly used to deliver health care to patients. The CDC reported a 154% increase in telehealth visits in the United States during the last week of March 2020, compared with the same period in 2019.2

Dermatology, being a visual specialty, is particularly well suited to telemedicine. Moreover, in India, where qualified dermatologists are concentrated in and around urban areas, and roughly one dermatologist caters to a population of 1.3 lacs,3 teledermatology can be an effective tool to meet patient needs, particularly for those in rural areas. With the rising number of smartphone users in India, smartphone-based teledermatology can be a convenient way for patients to utilize teledermatology services. As of December 2019, more than 50 crore (about 37% of the population) Indians were using smartphones, a 15% increase from 2018.4 Smartphone use in rural India also rose from 9% in 2015 to 25% in 2018.5

Study background

We started providing a hybrid teledermatology service, combining elements from both store-and-forward and real-time conferencing, using a 4G android smartphone and the WhatsApp messenger application to patients during the COVID pandemic since early April 2020.6 As per the institute policy, only follow-up patients were given teleconsultations. Patients take an appointment for teleconsultation through a dedicated institute helpline number or through the institute website. A team of resident doctors (MD trainees and post-MD senior residents) under the supervision of a faculty member contact the patients on the day of their scheduled appointment between 9 am and 2 pm through a voice call, discuss with them about their skin disease and ask them to send the pictures of their skin lesions along with previous medical records through the WhatsApp messenger. Patient condition is assessed, a note is made of their disease status and discussed with the faculty member as required. The patient is again contacted using voice call shortly thereafter and the treatment explained in detail. The prescription is sent to the patient either through WhatsApp (as an image of the signed prescription) or SMS. In case of an earlier failed attempt, another attempt is made to contact the patient; oncein the middle of the session (9am-2pm) and again before closing the session.

In this study, we aimed to study patient perception and satisfaction with this smartphone-based teledermatology service, initiated during the COVID-19 pandemic.

Methods

This was a cross-sectional telephonic survey conducted at the department of Dermatology and Venereology of the All India Institute of Medical Sciences, New Delhi that caters largely to the population of North India, after obtaining approval from The Institute Ethics Committee. Patients ≥18 years of age who had received a teledermatology consult during December 2020 to April 2021 were included after they gave their verbal informed consent. They were interviewed telephonically within two weeks of their last teledermatology consultation, by an investigator (DY) not affiliated with our department at the time of the study. Before the interview commenced, all the participants were informed that the interviewer is no longer affiliated with our institute, and that their responses would not affect their future care. After noting the demographic, clinical and teleconsultation details, patients were administered the Telemedicine Satisfaction Questionnaire and an additional 6-item questionnaire. They were also asked to give their feedback regarding their perception and satisfaction with our teledermatology services and suggestions for improvement using a semi-structured interview guide. In cases where teleconsultation was provided to the primary caregiver instead of the patients themselves, the survey was administered to the primary caregiver. The telephonic interviews were recorded and transcribed verbatim.

Patient satisfaction measures

The Telemedicine Satisfaction Questionnaire is a validated instrument developed for the evaluation of patient satisfaction with telemedicine.7 It consists of 14 items, categorized into three domains: quality of care provided, similarity to face-to-face encounter and perception of interaction. Responses to all items are on a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree), with the total questionnaire score ranging from 14 to 70. We developed a Hindi translation of the Telemedicine Satisfaction Questionnaire using the standard forward-and-back translation process for the purpose of this study as follows: the English version of the Telemedicine Satisfaction Questionnaire was translated into Hindi by two investigators proficient in the language independently (SB and DY), and a final version was mutually agreed on. This version was then translated back into English by another investigator (VG), which was then compared with the original English version of the Telemedicine Satisfaction Questionnaire to confirm that the meaning remained unchanged.

An additional set of six questions, developed specifically for this study, based on literature review and expert opinion, was also administered. These questions were particularly related to teledermatology and our method of providing teledermatology services, such as waiting to receive the call for teleconsult, taking and sending photographs of skin lesions, concerns about privacy of sharing photographs, preference for teleconsults or conventional hospital visits, and quality of teleconsultation and medical care. Responses to all these questions were on a 5-point Likert scale, as for the Telemedicine Satisfaction Questionnaire.

Statistical analysis

Continuous variables were reported as mean (± standard deviation, range), and categorical variables as frequency (%). Categorical variables were compared using Chi-square test or Fisher’s exact test, as applicable. Patient and teleconsult variables associated with patient satisfaction were identified by univariable and stepwise multivariable logistic regression analysis using dichotomized Telemedicine Satisfaction Questionnaire scores <4 and ≥4. Variables found to be significant up to 25% level under crude analysis were considered for stepwise procedure (with a probability to enter and remove 0.10 and 0.15, respectively). P<0.05 was considered statistically significant. Statistical analysis was done using Stata version 14.2 (StataCorp, College Station, TX, U. S. A.).

Results

We provided 1274 teledermatology consultations from December 2020 to April 2021. Three hundred and sixty-six patients, recruited through convenience sampling, were contacted for the telephonic survey. Of these, 122 could not be contacted for the interview, 18 did not consent to participate in the study and 25 were excluded because they were less than 18 years of age. Data for the remaining 201 subjects appears below.

Demographic, clinical and teleconsultation profile of the patients

Two hundred and one individuals were interviewed; 144 (71.6%) were patients themselves and 57 (28.4%) were primary caregivers. The mean age of patients was 38.41± 15.76 (range 18–77) years. There were 109 (54.2%) males and 92 (45.8%) females. A majority (123, 61.2%) of the patients had completed graduation or received higher education. Eighty-four (41.8%) patients resided outside the national capital territory of Delhi, and 118 (58.7%) patients reported needing >1 hour to travel to our hospital from their place of residence. The most common diagnoses were pemphigus (27, 13.4%), superficial fungal infections (24, 11.8%), psoriasis (22, 10.9%), dermatitides (21, 10.4%), acne (17, 8.4%) and vitiligo (16, 7.9%). Nineteen (9.5%) patients had more than one skin disease. Table 1 summarizes the demographic, clinical and teleconsultation characteristics of the patients.

Table 1: Demographic, clinical and teleconsultation characteristics of the patients (n=201)
Variable Result
Gender, n(%)
Men 109 (54.2%)
Women 92 (45.8%)
Age (years), mean±SD 38.4 ± 15.7
Education, n(%)
No formal education 33 (16.4%)
Till class 12 45 (22.4%)
Graduate or postgraduate 123 (61.2%)
Residence, n(%)
National capital territory of Delhi 117 (58.2%)
Outside National capital territory 84 (41.8%)
of Delhi
Usual time to reach hospital from residence, n(%) (h)
≤1 83 (41.3%)
>1 118 (58.7%)
Diagnosis, n(%)*
Acne and related disorders
Acne vulgaris 17 (8.4%)
Folliculitis 2 (0.9%)
Rosacea 2 (0.9%)
Hair disorders
Androgenetic alopecia 7 (3.4%)
Alopecia areata 7 (3.4%)
Hair fall 2 (0.9%)
Dermatitis
Endogenous dermatitis/atopic 11 (5.4%)
dermatitis
Parthenium dermatitis 1 (0.4%)
Seborrheic dermatitis 4 (1.9%)
Pruritus/prurigo 5 (2.4%)
Papulosquamous disorders
Psoriasis 22 (10.9%)
Pityriasis rubra pilaris 3 (1.4%)
Lichen planus 10 (4.9%)
Urticaria 12 (5.9%)
Leprosy 8 (3.9%)
Lichen planus 11 (5.4%)
Melasma 8 (3.9%)
Immunobullous disorders
Pemphigus 27 (13.4%)
Bullous pemphigoid 1 (0.4%)
Connective tissue diseases
Lupus erythematous 3 (1.4%)
Systemic sclerosis 2 (0.9%)
Small vessel vasculitis 1 (0.4%)
Superficial fungal infections
Dermatophytosis 22 (10.9%)
Candidal infections 2 (0.9%)
Vitiligo 16 (7.9%)
Skin and soft tissue bacterial 3 (1.4%)
infections
Scars (keloid/post-acne/ 6 (2.9%)
post-traumatic)
Others
Pityriasis rosea 1 (0.4%)
Chronic arsenicosis 1 (0.4%)
Atypical mycobacterial infections 1 (0.4%)
Chilblains 1 (0.4%)
Drug rash with eosinophilia and 2 (0.9%)
systemic symptoms
Fixed drug eruption 1 (0.4%)
Freckles 1 (0.4%)
Fingernail discolouration 1 (0.4%)
Herpetic infections 2 (0.9%)
Palmoplantar hyperhidrosis 2 (0.9%)
Port-wine stain 1 (0.4%)
Radiation dermatitis 1 (0.4%)
Subcorneal pustular dermatosis 1 (0.4%)
Zoon’s balanitis 1 (0.4%)
Warts 1 (0.4%)
Lichen planus pigmentosus 1 (0.4%)
Skin disease per patient, n(%)
1 182 (90.5%)
>1 (range 2–4) 19 (9.5%)
Reason for teleconsultation, n(%)
Regular follow-up 156 (77.6%)
Disease flare 29 (14.4%)
New unrelated complaint 14 (6.9%)
Other reason 2 (0.9%)
Teleconsultation advice, n(%)
Continue same treatment 104 (51.7%)
Treatment changed 72 (35.8%)
Asked to visit hospital 25 (12.4%)
Number of teleconsultations
received, n(%)
1 95 (47.3%)
>1 (range 2–15, median 3) 106 (52.7%)
Skin disease, n (%)
Same 94 (46.7%)
Better 91 (45.2%)
Worse 16 (8%)
Some patients had >1 diagnosis

Satisfaction scores

The overall mean Telemedicine Satisfaction Questionnaire score was 4.20± 0.71 indicating that patients were generally satisfied with the teledermatology services. The mean scores of the three domains “quality of care provided,” “similarity to face-to-face encounter” and “perception of interaction” were 4.13± 0.75, 4.28± 0.70 and 4.40± 0.96, respectively. All except two items in the Telemedicine Satisfaction Questionnaire had a mean score ≥4 (agree or strongly agree): “as if met in person” (3.82± 1.19) and “healthcare is consistent” (3.99± 1.07). The highest score was for an item pertaining to saving time travelling to the hospital, with a mean score of 4.70± 0.58. An overall Telemedicine Satisfaction Questionnaire score ≥4 was recorded by 139 (69.2%) patients. One hundred and seventy one (85.1%) patients said that they would use telemedicine services again, while 168 (83.6%) patients reported being satisfied with the quality of telemedicine services.

Of the six additional questions, three had a mean score ≥4. The items with a score of <4 were related to “preference for telemedicine over going to hospital” (3.93± 1.23), “medical care being as good as going to hospital” (3.79± 1.23) and “not being able to see the doctor not reducing the quality of consultation” (3.83± 1.20). Figure 1 shows the mean scores and break-up of patient responses for all items of the Telemedicine Satisfaction Questionnaire and additional questions.

The mean scores and break-up of patient responses for all items of the Telemedicine Satisfaction Questionnaire and our additional questionnaire
Figure 1:
The mean scores and break-up of patient responses for all items of the Telemedicine Satisfaction Questionnaire and our additional questionnaire

Qualitative feedback

A majority of the respondents broadly expressed satisfaction with the various components involved in our teledermatology services, particularly the convenience and time saved. The major areas of concern that emerged included the quality of medical care being perceived as lower than with physical consults, difficulty in procuring medicines due to either their unavailability nearby or the e-prescription not being considered valid by pharmacists, lack of a personal touch during the consultation, lack of confidence in the tele-assessments and perceived difficulty in conveying problems to the doctor. The qualitative feedback provided by patients and primary caregivers was largely similar. Table 2 summarizes the responses to the semi-structured interview guide.

Table 2: Summary of responses to the semi-structured interview guide
Themes covered in the semi-structured interview guide Sub-themes Patient quotes
Receiving doctor’s call At inconvenient times: 4/201 (19.9%) “Got a call during office hours”
“Call interrupted my online class”
No specific time of call: 43/201 (21.4%) “Kept on waiting for the call”
“There should be a fixed time for call”
“Doctor’s call can come anytime…”
“A message could be sent that the doctor will call around 10 am.”
“… I can be better prepared with my records”
Conveying problems to doctor Not enough time spent: 21/201 (10.4%) “Doctor seemed to be in a hurry”
“… should ask more questions”
“… should give more time to tell our problems”
“Sometimes I am not able to convey all my problems”
Inability to convey problems: 10/201 “I could not explain properly on the phone”
(4.9%) “I remembered something later…”
Lack of personal touch: 32/201 (15.9%) “Video-call option should be there for those who want it”
“Video-call will give a personal touch”
“It can make it more like a physical consult”
“Seeing the doctor’s face will give me more satisfaction”
Better attention: 2/201 (0.9%) “I felt that the doctor was giving attention to only me, unlike in the OPD”
Understanding doctor’s advice Easier to understand: 4/201 (1.9%) “I can record the conversation and listen to it later, if I have any doubt”
Doctor being able to understand Unsure if doctor understood the problem: “Doctors don’t understand completely…”
patient’s problem 11/201 (5.4%) “Assessment on photographs is not as good as on physical examination”
“I could not clearly point out new vitiligo lesions on the photograph”
Lack of confidence in photographic “I don’t know how much the doctor understands by looking at
assessments: 29/201 (14.4%) photographs”
“Skin diseases require touch…”
“I don’t know how clearly skin lesions are seen on photos”
Clicking and sending photographs to Privacy concerns: 14/201 (6.9%) “I don’t want to send my photograph as I am a girl”
doctor “I feel embarrassed in sending photographs of the genital area”
Difficulty in clicking photos: 5/201 “I cannot click photos of my back”
(2.5%) “Someone else clicks photos for me”
“I need help in clicking photos”
“I cannot send photos of my entire body”
Taking an appointment for Difficulty in taking an appointment “The phone is always busy”
telemedicine telephonically: 34/201 (16.9%) “I had to try daily for 5-6 days”
“No one answers the phone”
Difficulty in taking an online “I don’t know how to take an appointment”
appointment: 27/201 (13.4%) “Website hangs a lot”
“It has so many steps, complex process. Needs OTP (one-time
password).”
“It should be modernized and made more user-friendly”
“… easier if doctors themselves can give the next appointment”
Buying medicines through a SMS or Avoids prescription errors (1.5%) “…now the chemist does not have to deal with the doctor’s
WhatsApp prescription hand-writing”
Difficulty in getting medicines through “Prescription was not accepted by my local chemist and many online
SMS prescription: 23/201 (11.4%) pharmacies”
“SMS prescription does not look authentic”
“Prescription should have the doctor’s name”
“I had to show an old prescription to get my refill”
“Difficult to get the bill reimbursed”
Overall process of the telemedicine Complex process: 24/201 (11.9%) “My mother cannot do it by herself as she is old”
process “It is easier for people who know computers…”
“I need help with teleconsultation”
Lack of continuity: 37/201 (18.4%) “A different doctor calls at every appointment”
“I have to start from scratch every time…”
“Previous clinical records should be saved to make it less cumbersome”
“I wanted to speak to my senior doctor”
“I don’
Convenience, time taken, expense Cost-effective and more convenient: “I don’t have to take leave from work”
28/201 (13.9%) “Earlier, I used to miss physical appointments due to lack of time or
money”
“… avoids waiting in crowded outpatient departments”
“Doctors call back at a more convenient time if we request them”
Difficult to procure medicines without “Medicines are costly, which were earlier available for free from the
hospital visit: 27/201 (13.4%) hospital pharmacy”
“Medicines are costlier than my travel to hospital…”
“Prescribed medicines were not available in my hometown”
“Hospital should do free home delivery of medicines”
“I am not sure of the quality of medicines available here (in my
hometown)”
“Brand names of medicines should be written in the prescription”
Others Quality of care not at par with physical “… not as good as physical visits for severe skin disease”
consults: 57/201 (28.3%) “Teleconsultation is fine as long as disease is improving; urgent
appointment for an outpatient visit should be given if worsening”
“I cannot get phototherapy for my vitiligo”
“Appointment for a physical visit should be given after a few
tele-appointments”
“I prefer teleconsultation only during COVID times”
“Less expensive, but at the cost of quality”
Cannot initiate the contact with the “… in case of emergency”
doctor: 13/201 (6.5%) “…if I have to clear any doubt”
“I cannot call back if I missed the call earlier”

Factors affecting satisfaction with teledermatology services

A diagnosis of urticaria (vs. other diagnoses, P=0.020) and improvement in skin disease following the last teleconsultation advice (vs. disease remained unchanged or worsened, P=0.013) were significantly associated with patient satisfaction under crude analysis. Univariable logistic regression analysis showed patients whose skin disease improved (OR 2.19, P=0.014) and who were advised a change in treatment (vs. treatment unchanged, OR 2.09, P=0.037) were more likely to be satisfied with the teledermatology services. Table 3 shows the results of crude analysis and univariable logistic regression analysis for factors associated with overall patient satisfaction with our teledermatology services (Telemedicine Satisfaction Questionnaire ≥4).

Table 3: Crude analysis and univariable logistic regression analysis showing factors associated with overall patient satisfaction with our teledermatology services (Telemedicine Satisfaction Questionnaire score ≥4 )
Variable No. of patients with
Telemedicine Satisfaction
Questionnaire score <4
(n=62)
No. of patients with
Telemedicine Satisfaction
Questionnaire score ≥4
(n=139)
P-value# OR (95% CI) P-value^
Age, years 0.658
<30 23 (37.1%) 54 (38.6%) 1
30–60 30 (48.4%) 71 (51.1%) 1.008 (0.527–1.927) 0.981
>60 9 (14.5%) 14 (10.1%) 0.6625 (0.251–1.746) 0.405
Gender 0.849
Male 33 (53.2%) 76 (54.8%) 1
Female 29 (46.7%) 63 (45.3%) 0.943 (0.518–1.719) 0.849
Education 0.294
No formal education 7 (11.3%) 26 (18.7%) 1
≤Class 12 17 (27.4%) 28 (20.1%) 0.443 (0.158–1.241) 0.122
Graduate/Post-graduate 38 (61.3%) 85 (61.2%) 0.602 (0.240–1.508) 0.279
Residence 0.978
Delhi/NCR 36 (58.1%) 81 (58.3%) 1
Outside Delhi/NCR 26 (41.9%) 58 (41.7%) 0.991 (0.540–1.818) 0.978
Usual time to reach hospital from 0.902
residence (h)
<1 26 (41.9%) 57 (41%) 1
>1 36 (58.1%) 82 (59%) 1.038 (0.566–1.907) 0.902
Diagnosis (vs. others)
Acne and related disorders 6 (9.7%) 15 (10.8%) 0.812 1.129 (0.416–3.062) 0.812
Eczema/papulosquamous disorders 17 (27.4%) 39 (28.1%) 0.926 1.032 (0.528–2.016) 0.926
Urticaria 0 (0%) 12 (8.6%) 0.020* - -
Superficial fungal infections 5 (8.1%) 19 (13.7%) 0.348 1.805 (0.641–5.077) 0.263
Immunobullous diseases 10 (16.1%) 18 (12.9%) 0.548 0.773 (0.334–1.789) 0.548
Vitiligo 6 (9.7%) 10 (7.2%) 0.548 0.723 (0.251–2.087) 0.549
Hair disorders 4 (6.5%) 11 (7.9%) >0.99 1.246 (0.381–4.078) 0.716
No. of skin diseases per patient 0.797
1 57 (91.9%) 125 (89.9%) 1
>1 5 (8.1%) 14 (10.1%) 1.276 (0.438–3.715) 0.654
Teleconsultation received by 0.887
Patient 44 (71%) 100 (71.9%) 1
Primary caregiver 18 (29%) 39 (28.1%) 0.953 (0.492–1.847) 0.887
No. of teleconsultations received 0.081
1 35 (56.5%) 60 (43.2%) 1
>1 27 (43.5%) 79 (56.8%) 1.706 (0.933–3.122) 0.083
Reason for teleconsultation 0.437
Disease flare/new complaint 16 (25.8%) 29 (20.9%) 1
Regular follow-up 46 (74.2%) 110 (79.1%) 1.319 (0.654–2.659) 0.438
Teleconsultation advice 0.065
Continue same treatment 37 (59.7%) 67 (48.2%) 1
Treatment changed 15 (24.2%) 57 (41%) 2.098 (1.046–4.209) 0.037*
Advised to visit hospital 10 (16.1%) 15 (10.8%) 0.828 (0.338–2.027) 0.680
Skin disease response after 0.013*
teleconsultation advice
Same/worse 42 (67.7%) 68 (48.9%) 1
Better 20 (32.3%) 71 (51.1%) 2.192 (1.170–4.107) 0.014*
Chi-square test or Fisher’s exact test, as applicable. ^Univariable logistic regression analysis. *Variables statistically significantly associated with patient satisfaction (Telemedicine Satisfaction Questionnaire score ≥4)

Diagnosis of urticaria was excluded from the regression model as the odds ratio could not be calculated. Multivariable analysis showed treatment change (OR 2.21, 95% CI 1.08– 4.52, P=0.029) and improvement in skin disease (OR 2.09, 95% CI 1.09–4.02, P=0.026) to be associated with overall patient satisfaction, while receiving teleconsults more than once (OR 1.79, 95%; CI 0.95–3.33, P=0.069) showed a trend toward an association but did not reach statistical significance.

Discussion

Telemedicine was virtually non-existent in India but the COVID-19 pandemic has thrust it to the forefront of the healthcare delivery system. Our telemedicine services were started during the lockdown due to the COVID-19 pandemic as an expediential measure to help patients access health services. We chose smartphone-based teledermatology using WhatsApp messenger because of its wide reach and feasibility. Smartphone-based teledermatology does not need dedicated infrastructure and therefore could be useful in resource-poor settings. Though patient satisfaction with conventional teledermatology has been shown to be generally high, not many studies have evaluated patient satisfaction with smartphone-based teledermatology in detail.8,9

Our results show a mean Telemedicine Satisfaction Questionnaire score of 4.20, suggesting that patients were largely satisfied with our teledermatology service. Earlier studies using a 5-point Likert scale have also reported comparable mean scores, ranging from 3.8 to 4.74. While some of these studies focused on patients in specific categories such as skin malignancies, cosmetic dermatology, acne or psoriasis, many included general dermatology patients like ours.10-15 About 84% of the patients in our survey reported being satisfied overall with the quality of telemedicine services, while about 69% of patients recorded an overall Telemedicine Satisfaction Questionnaire score ≥4. Around 85% patients said that they would use teledermatology again, a marker of its perceived usefulness. These results are consistent with those of previous studies, where satisfaction rates ranged from 77% to 90%.10,15-19 Time saved in travelling to hospital emerged as the most appreciated aspect (mean Telemedicine Satisfaction Questionnaire score 4.70; 96% patients agreed or strongly agreed). This has been highlighted in earlier studies as well.20,21

Patients were generally happy with the ease and comfort of telecommunication and the clarity of their interactions with the doctor in our study. However, patients did miss seeing their doctor during the teleconsultations, as we contacted the patients using a voice call; the items pertaining to this aspect had the lowest scores. Having an option of video-call was suggested by some patients to enhance the quality of the teleconsultation. An earlier study by Williams et al. also reported patients expressing lower satisfaction with the absence of face-to-face contact with doctor.22

Another important concern was regarding the quality of healthcare provided through teledermatology, as suggested by the low scores on the relevant items. Some of the reasons for this perception included not enough time spent on teleconsultation by the doctor, and perceived inability to convey all problems properly to the doctor and/or doubts if the doctor understood them. Still, about 70% (n=142/201) of our study patients preferred teleconsultations over hospital visits, and 66% (n=133/201) of them felt that medical care through teleconsultations was as good as going to the hospital, rates that were comparable to those in other studies.20,22

Patients also lacked confidence in the photographic diagnoses and assessments made without physical examination and had concerns regarding the clarity of skin lesions on photographs. Similar concerns regarding accuracy were expressed by about half of the patients in a study (n=123) from Australia by Chee et al.23 However, a recent study from Brazil reported high diagnostic accuracy (78% complete agreement with in-person examination, 8% partial agreement and 14% no agreement) for inflammatory dermatoses with store-and-forward teledermatology,24 while a systematic review suggests that smartphone-based teledermatology may have a similar or better diagnostic concordance than that of store-and-forward method.25

Unlike other medical specialties, photography of skin lesions is a unique and an integral part of teledermatology. Most of our patients did not express concerns regarding taking and sending the photographs (91%, n=183/201) or regarding privacy (90%, n=181/201). Williams et al. also reported that 85% of their 122 patients did not mind being photographed.22 On the other hand, 14% of patients refused photography citing social or religious reasons in a Saudi Arabian study (n=166) by Kaliyadan et al.9 while about 25% patients expressed concerns regarding privacy in the Australian study (n=123) by Chee et al.23

Qualitative feedback gave us insights into a few more issues that troubled our patients. Though seen as convenient and saving both time and money, some patients found telemedicine to be more expensive as they had to purchase medicines that were earlier available free of cost at our hospital. There is only limited literature formally evaluating the cost-effectiveness of teledermatology, but most studies suggest that it may be more economical, especially when indirect costs (such as lost productivity) are factored in. It may be particularly cost-effective for certain patient populations, such as those who live in remote areas with poor access to healthcare.26,27Another problem patients faced was finding the prescribed medications in their locality/hometown; it was easier to buy them from a medical store near the hospital when they came for a physical consultation. Further, SMS or WhatsApp prescriptions were not accepted by all chemists and online pharmacies, and there were difficulties in getting reimbursements for medications purchased using such prescriptions. Patient suggestions around these problems included having a physical consultation after every few teleconsultations, free home-delivery of medicines from the hospital pharmacy, and modifying e-prescriptions to make them look more authentic. These issues need the attention of healthcare policy makers for easier implementation of telemedicine services. Several countries have formulated regulations and have adopted e-prescription systems in community pharmacies at a national level.28

There are a few studies that have looked at factors associated with patient satisfaction with teledermatology. Williams et al. found that patients with a high burden of disease did not prefer teleconsultations.22 Hsueh et al. reported short waiting times before teleconsultation, perception of skin disease being properly treated and receiving adequate follow-up as factors associated with patient satisfaction.15 A recent Indian study by Handa et al. reported higher satisfaction levels among patients with dermatophytoses, infestations and bacterial infections,29 while dermatologists perceived superficial skin infections, acne, eczemas and pigmentary disorders to be particularly suited for telemedicine.30,31 We found that patients with urticaria were more likely to be satisfied with teledermatology than those with other diagnoses, probably because the disease is seen as non-serious, assessment is largely based on patient history, and it is amenable to easy treatment titrations on teleconsultations. As expected, patients whose skin disease improved after the teleconsultations were more satisfied than those whose disease remained unchanged or worsened, while patients who were advised a change in treatment were also more satisfied. In general, patients who are advised a change in treatment plan may feel that their problems have been better attended, though this may not always be true. Similarly, in another study, patients who were only reassured were less satisfied than those who were advised a skin biopsy or a face-to-face evaluation.32 We noted a trend for better satisfaction in patients who had received more than one teleconsult, presumably because of increased familiarity with the process. We expected patients from outside the state and those with long travelling hours to the hospital to be more satisfied with teledermatology, but this was not the case in our results. Patient satisfaction was found to be independent of distance from hospital in the study by Handa et al. as well.29 Younger and more educated patients are more likely to be at ease with new technology, and therefore more receptive of teledemedicine, but we did not find any association of patient satisfaction with age or education status.

Most of the earlier studies on patient satisfaction with telemedicine used non-validated instruments. We used the Telemedicine Satisfaction Questionnaire, a validated instrument developed for this purpose.7 As this was a general telemedicine instrument, we supplemented it with a few of our own questions particularly relevant to teledermatology. In addition, patient’s qualitative feedback and their suggestions were also collected.

Limitations

Our study was conducted during the COVID-19 pandemic, when the acceptability of telemedicine services is likely to be higher. Statistically significantly higher mean satisfaction scores were recorded for the patients receiving teledermatology consultation for the first time during the COVID-19 pandemic compared to those who had received it before the pandemic as well (4.7 vs. 4.4, P=0.03) in a study by Hamad et al.33 As we were providing teleconsultations only to patients who had previously been seen in person, patients seeking a consultation for the first time were not included in the study. Some aspects of patient experience, such as reduced waiting times for an appointment with teledermatology vis-à-vis physical visits, were not studied. We recruited the participants through convenience sampling; though this sampling method is used commonly in qualitative research, it puts the results at a risk of potential bias.

Conclusion

Our results suggest that patients find telemedicine a convenient, time-saving and cost-effective alternative to physical hospital visits. Satisfaction levels were generally high with our smartphone-based teledermatology service. Our study identified certain lacunae that negatively impact patient perception and satisfaction; addressing them might help in greater acceptance of teledermatology services.

Declaration of patient consent

Institutional Review Board (IRB) permission obtained for the study.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , , , , , , et al. Teledermatology and its current perspective. Indian Dermatol Online J. 2020;11:12-20.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , , et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic-United States, January-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1595-9.
    [CrossRef] [PubMed] [Google Scholar]
  3. , . Teledermatology in the wake of COVID-19 scenario: An Indian perspective. Indian Dermatol Online J. 2020;11:301-6.
    [CrossRef] [PubMed] [Google Scholar]
  4. . Available from: https://www.indiatimes.com/technology/news/india-loves-smartphones-over-50-crore-indians-use-smartphones-77-use-internet-reveals-report-505413.html [Last accessed on 2021 Jun 14]
  5. , . COVID-19 pandemic ushering in the era of teledermatology. Indian J Dermatol Venereol Leprol. 2021;87:436-7.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , . Development of the telemedicine satisfaction questionnaire to evaluate patient satisfaction with telemedicine: A preliminary study. J Telemed Telecare. 2003;9:46-50.
    [CrossRef] [PubMed] [Google Scholar]
  7. . Newer insights in teledermatology practice. Indian J Dermatol Venereol Leprol. 2011;77:276-87.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , . Mobile teledermatology-patient satisfaction, diagnostic and management concordance, and factors affecting patient refusal to participate in Saudi Arabia. J Telemed Telecare. 2013;19:315-9.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , . Definitions, survey methods, and findings of patient satisfaction studies in teledermatology: A systematic review. Arch Dermatol Res. 2021;313:205-15.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , , , , et al. Impact of direct to consumer store-and-forward teledermatology on access to care, satisfaction, utilization, and costs in a commercial health plan population. Telemed J E Health. 2018;24:166-9.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , , . Patient and provider satisfaction with teledermatology. Telemed J E Health. 2017;23:684-90.
    [CrossRef] [PubMed] [Google Scholar]
  12. , , , , , , et al. Patient satisfaction with dermatology teleconsultation by using MedX. Comput Methods Programs Biomed. 2018;167:37-42.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , , et al. Teledermatologic consultation and reduction in referrals to dermatologists: A cluster randomized controlled trial. Arch Dermatol. 2009;145:558-64.
    [CrossRef] [PubMed] [Google Scholar]
  14. , , , , . Teledermatology patient satisfaction in the Pacific Northwest. Telemed J E Health. 2012;18:377-81.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , . Randomized and controlled pilot study of the pragmatic use of mobile phone based follow up of actinic keratoses treated with topical 5-fluorouracil. Dermatol Online J. 2018;24:19.
    [CrossRef] [Google Scholar]
  16. , . Does teledermatology reduces secondary care referrals and is it acceptable to patients and doctors?: A service evaluation. J Eval Clin Pract. 2015;21:710-6.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , . Teledermatology: A tool for remote supervision of a general practitioner with special interest in dermatology. Clin Exp Dermatol. 2011;36:489-94.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Usability, acceptability, and impact of a pediatric teledermatology mobile health application. Telemed J E Health. 2018;24:236-45.
    [CrossRef] [PubMed] [Google Scholar]
  19. , , , . Patient satisfaction with a new skin cancer teledermatology service. Clin Exp Dermatol. 2020;45:691-8.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , . Effect of real-time teledermatology on diagnosis, treatment and clinical improvement. J Telemed Telecare. 2015;21:93-9.
    [CrossRef] [PubMed] [Google Scholar]
  21. , , , , , , et al. Patient satisfaction with teledermatology is related to perceived quality of life. Br J Dermatol. 2001;145:911-7.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , . Smartphone patient monitoring post-laser resurfacing. Australas J Dermatol. 2017;58:e216-22.
    [CrossRef] [PubMed] [Google Scholar]
  23. , , . Part I: Accuracy of teledermatology in inflammatory dermatoses. Front Med (Lausanne). 2020;7:585792.
    [CrossRef] [PubMed] [Google Scholar]
  24. , , , . Systematic review of mobile phone-based teledermatology. Arch Dermatol Res. 2018;310:675-89.
    [CrossRef] [PubMed] [Google Scholar]
  25. , , , , . Cost-effectiveness of store-and-forward teledermatology: A systematic review. JAMA Dermatol. 2016;152:702-8.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption? J Am Acad Dermatol. 2020;83:299-307.
    [CrossRef] [PubMed] [Google Scholar]
  27. , . Digital health in physicians' and pharmacists' office: A comparative study of e-prescription systems' architecture and digital security in eight countries. OMICS. 2021;25:102-2.
    [CrossRef] [PubMed] [Google Scholar]
  28. , , , , , , et al. Teledermatology during the COVID-19 pandemic: Experience at a tertiary care centre in North India. Dermatol Ther. 2021;34:e15022.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , . Dermatologists' perceptions on the utility and limitations of teledermatology after examining 55, 000 lesions. J Telemed Telecare. 2021;27:166-73.
    [CrossRef] [PubMed] [Google Scholar]
  30. , . Teledermatology: Clinical case profiles and practical issues. Indian J Dermatol Venereol Leprol. 2009;75:32-5.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , . Patient satisfaction with the veteran's administration teledermatology service. J Am Acad Dermatol 2019:S0190-9622(19)30143-4. Epub ahead of print
    [CrossRef] [Google Scholar]
  32. , , , , . Evaluating the experiences of new and existing teledermatology patients during the COVID-19 pandemic: Cross-sectional survey study. JMIR Dermatol. 2021;4:e25999.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections